Insights From HumanFirst Show Breadth of Pharmaceutical Investment in AI/ML and Digital Endpoints in Clinical Trials

For the first time, HumanFirst Institute’s analysis puts numbers to the digital biomarker and clinical outcome assessment (COA) revolution happening in life sciences SAN FRANCISCO, Sept. 28, 2023 /PRNewswire/ — Regulators are increasingly approving AI-powered endpoints using digital…

Click here to view original post